Article
Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and…
Pharmacogenomics and Personalized Medicine · 2019 · Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, Na Nakorn C, Sukasem C, Kroll MH
Key facts
| Title | Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia |
|---|---|
| First author | Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, Na Nakorn C, Sukasem C, Kroll MH |
| Journal | Pharmacogenomics and Personalized Medicine |
| Published | Aug 6, 2019 |
| DOI | 10.2147/PGPM.S210770 |
| Devices mentioned | 210770, K000568, K010337, K013662, K033610, K143691, K162593, K963213, K981580 |
| Product codes mentioned | CZW, JIX, JJY, JHO, LBR, LBS, LBT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1